Oncosil Medical Ltd (OSL)

Sydney
Currency in AUD
Disclaimer
0.011
0.000
(0.00%)
Delayed Data
Trading near 52-week Low
Day's Range
0.011
0.012
52 wk Range
0.011
0.065
Volume
409,081
Prev. Close
0.012
Open
0.012
Day's Range
0.011-0.012
52 wk Range
0.011-0.065
Volume
409,081
Average Volume (3m)
2,207,496
1-Year Change
-62.96%
Shares Outstanding
989,242,262
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More

Oncosil Medical Ltd News

Oncosil Medical Ltd Analysis

Oncosil Medical Ltd Company Profile

OncoSil Medical Ltd is an Australia-based company, which is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and bile duct cancer. OncoSil is a single-use brachytherapy (internal radiation) device used to deliver a pre-determined dose of beta radiation directly into cancerous tissue. OncoSil is comprised of Microparticles that contain a radioisotope and a specially formulated Diluent, which acts as a carrier to facilitate the implantation of the Microparticles into the target tissue. OncoSil is indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The OncoSil System is supplied sterile and is intended for single-patient, single-use. OncoSil is approved in the various jurisdictions, including European Union, United Kingdom, Hong Kong, Singapore, Malaysia, New Zealand and Switzerland.